Cargando…

Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda

BACKGROUND: While most Sub-Saharan African countries are now implementing the WHO-recommended Option B+ protocol for prevention of vertical HIV transmission, there is a lack of knowledge regarding the influence of Option B+ exposure on adverse birth outcomes (ABOs). Against this background, we asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Rempis, Eva M., Schnack, Alexandra, Decker, Sarah, Braun, Vera, Rubaihayo, John, Tumwesigye, Nazarius Mbona, Busingye, Priscilla, Harms, Gundel, Theuring, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341453/
https://www.ncbi.nlm.nih.gov/pubmed/28270119
http://dx.doi.org/10.1186/s12884-017-1263-2
_version_ 1782512993796358144
author Rempis, Eva M.
Schnack, Alexandra
Decker, Sarah
Braun, Vera
Rubaihayo, John
Tumwesigye, Nazarius Mbona
Busingye, Priscilla
Harms, Gundel
Theuring, Stefanie
author_facet Rempis, Eva M.
Schnack, Alexandra
Decker, Sarah
Braun, Vera
Rubaihayo, John
Tumwesigye, Nazarius Mbona
Busingye, Priscilla
Harms, Gundel
Theuring, Stefanie
author_sort Rempis, Eva M.
collection PubMed
description BACKGROUND: While most Sub-Saharan African countries are now implementing the WHO-recommended Option B+ protocol for prevention of vertical HIV transmission, there is a lack of knowledge regarding the influence of Option B+ exposure on adverse birth outcomes (ABOs). Against this background, we assessed ABOs among delivering women in Western Uganda. METHODS: A cross-sectional, observational study was performed within a cohort of 412 mother-newborn-pairs in Virika Hospital, Fort Portal in 2013. The occurrence of stillbirth, pre-term delivery, and small size for gestational age (SGA) was analysed, looking for influencing factors related to HIV-status, antiretroviral drug exposure and duration, and other sociodemographic and clinical parameters. RESULTS: Among 302 HIV-negative and 110 HIV-positive women, ABOs occurred in 40.5%, with stillbirth in 6.3%, pre-term delivery in 28.6%, and SGA in 12.2% of deliveries. For Option B+ intake (n = 59), no significant association was found with stillbirth (OR 0.48, p = 0.55), pre-term delivery (OR 0.97, p = 0.92) and SGA (OR 1.5, p = 0.3) compared to seronegative women. Women enrolled on antiretroviral therapy (ART) before conception (n = 38) had no different risk for ABOs than women on Option B+ or HIV-negative women. Identified risk factors for stillbirth included lack of formal education, poor socio-economic status, long travel distance, hypertension and anaemia. Pre-term delivery risk was increased with poor socio-economic status, primiparity, Malaria and anaemia. The occurrence of SGA was influenced by older age and Malaria. CONCLUSION: In our study, women on Option B+ showed no difference in ABOs compared to HIV-negative women and to women on ART. We identified several non-HIV/ART-related influencing factors, suggesting an urgent need for improving early risk assessment mechanisms in antenatal care through better screening and triage systems. Our results are encouraging with regard to continued universal scale-up of Option B+ and ART programmes.
format Online
Article
Text
id pubmed-5341453
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53414532017-03-10 Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda Rempis, Eva M. Schnack, Alexandra Decker, Sarah Braun, Vera Rubaihayo, John Tumwesigye, Nazarius Mbona Busingye, Priscilla Harms, Gundel Theuring, Stefanie BMC Pregnancy Childbirth Research Article BACKGROUND: While most Sub-Saharan African countries are now implementing the WHO-recommended Option B+ protocol for prevention of vertical HIV transmission, there is a lack of knowledge regarding the influence of Option B+ exposure on adverse birth outcomes (ABOs). Against this background, we assessed ABOs among delivering women in Western Uganda. METHODS: A cross-sectional, observational study was performed within a cohort of 412 mother-newborn-pairs in Virika Hospital, Fort Portal in 2013. The occurrence of stillbirth, pre-term delivery, and small size for gestational age (SGA) was analysed, looking for influencing factors related to HIV-status, antiretroviral drug exposure and duration, and other sociodemographic and clinical parameters. RESULTS: Among 302 HIV-negative and 110 HIV-positive women, ABOs occurred in 40.5%, with stillbirth in 6.3%, pre-term delivery in 28.6%, and SGA in 12.2% of deliveries. For Option B+ intake (n = 59), no significant association was found with stillbirth (OR 0.48, p = 0.55), pre-term delivery (OR 0.97, p = 0.92) and SGA (OR 1.5, p = 0.3) compared to seronegative women. Women enrolled on antiretroviral therapy (ART) before conception (n = 38) had no different risk for ABOs than women on Option B+ or HIV-negative women. Identified risk factors for stillbirth included lack of formal education, poor socio-economic status, long travel distance, hypertension and anaemia. Pre-term delivery risk was increased with poor socio-economic status, primiparity, Malaria and anaemia. The occurrence of SGA was influenced by older age and Malaria. CONCLUSION: In our study, women on Option B+ showed no difference in ABOs compared to HIV-negative women and to women on ART. We identified several non-HIV/ART-related influencing factors, suggesting an urgent need for improving early risk assessment mechanisms in antenatal care through better screening and triage systems. Our results are encouraging with regard to continued universal scale-up of Option B+ and ART programmes. BioMed Central 2017-03-07 /pmc/articles/PMC5341453/ /pubmed/28270119 http://dx.doi.org/10.1186/s12884-017-1263-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rempis, Eva M.
Schnack, Alexandra
Decker, Sarah
Braun, Vera
Rubaihayo, John
Tumwesigye, Nazarius Mbona
Busingye, Priscilla
Harms, Gundel
Theuring, Stefanie
Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title_full Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title_fullStr Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title_full_unstemmed Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title_short Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
title_sort option b+ for prevention of vertical hiv transmission has no influence on adverse birth outcomes in a cross-sectional cohort in western uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341453/
https://www.ncbi.nlm.nih.gov/pubmed/28270119
http://dx.doi.org/10.1186/s12884-017-1263-2
work_keys_str_mv AT rempisevam optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT schnackalexandra optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT deckersarah optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT braunvera optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT rubaihayojohn optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT tumwesigyenazariusmbona optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT busingyepriscilla optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT harmsgundel optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda
AT theuringstefanie optionbforpreventionofverticalhivtransmissionhasnoinfluenceonadversebirthoutcomesinacrosssectionalcohortinwesternuganda